FI962220A - Transdermaalinen terapeuttinen järjestelmä - Google Patents
Transdermaalinen terapeuttinen järjestelmä Download PDFInfo
- Publication number
- FI962220A FI962220A FI962220A FI962220A FI962220A FI 962220 A FI962220 A FI 962220A FI 962220 A FI962220 A FI 962220A FI 962220 A FI962220 A FI 962220A FI 962220 A FI962220 A FI 962220A
- Authority
- FI
- Finland
- Prior art keywords
- pct
- active substance
- therapeutic system
- transdermal therapeutic
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4342174A DE4342174C1 (de) | 1993-12-10 | 1993-12-10 | Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung |
DE4342174 | 1993-12-10 | ||
EP9404048 | 1994-12-06 | ||
PCT/EP1994/004048 WO1995015755A1 (de) | 1993-12-10 | 1994-12-06 | Transdermales therapeutisches system zur prophylaxe einer vergiftung durch phosphororganische nervengifte bestehend aus einer wirkstoffkombination von einem parasympathikomimetikum und einem parasympathikolytikum |
Publications (3)
Publication Number | Publication Date |
---|---|
FI962220A0 FI962220A0 (fi) | 1996-05-27 |
FI962220A true FI962220A (fi) | 1996-06-27 |
FI122131B FI122131B (fi) | 2011-09-15 |
Family
ID=6504684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI962220A FI122131B (fi) | 1993-12-10 | 1996-05-27 | Menetelmä transdermaalisen terapeuttisen järjestelmän valmistamiseksi, joka on tarkoitettu myrkyllisen organofosforihermomyrkyn myrkytyksen ennaltaehkäisyyn tai esikäsittelyyn |
Country Status (19)
Country | Link |
---|---|
US (1) | US5939095A (fi) |
EP (1) | EP0732924B1 (fi) |
JP (1) | JP3739789B2 (fi) |
KR (1) | KR100397361B1 (fi) |
AT (1) | ATE433339T1 (fi) |
CA (1) | CA2178603C (fi) |
CZ (1) | CZ291057B6 (fi) |
DE (2) | DE4342174C1 (fi) |
ES (1) | ES2329426T3 (fi) |
FI (1) | FI122131B (fi) |
HU (1) | HUT74432A (fi) |
IL (1) | IL111942A (fi) |
MY (1) | MY111715A (fi) |
NO (1) | NO962405L (fi) |
NZ (1) | NZ277492A (fi) |
PL (1) | PL314914A1 (fi) |
SK (1) | SK284356B6 (fi) |
WO (1) | WO1995015755A1 (fi) |
ZA (1) | ZA949842B (fi) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19743484C1 (de) * | 1997-10-01 | 1999-01-28 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems |
US7011843B2 (en) * | 1997-10-01 | 2006-03-14 | Lts Lohmann-Therapie Systeme Ag | Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system |
AU775914B2 (en) * | 1998-12-24 | 2004-08-19 | Janssen Pharmaceutica N.V. | Controlled release galantamine composition |
AU2003228796A1 (en) * | 2002-05-01 | 2003-11-17 | Eisai Co., Ltd. | Cholinesterase inhibitors to prevent injuries caused by chemicals |
DE10301851A1 (de) * | 2003-01-17 | 2004-07-29 | Lts Lohmann Therapie-Systeme Ag | Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel |
US20050013869A1 (en) * | 2003-07-18 | 2005-01-20 | Chaw Cheng Shu | Sustained release formulation for carbamates and a method therefor |
US8299062B2 (en) * | 2003-09-17 | 2012-10-30 | Franklin Volvovitz | Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction |
US20070093518A1 (en) * | 2003-09-19 | 2007-04-26 | Wetherell Janet R | Pharmaceutical compositions for the treatment of organophosphate poisoning |
AU2012200612B2 (en) * | 2004-09-24 | 2014-11-20 | The Government Of The United States, As Represented By The Secretary Of The Army | Method of treating organophosphorus poisoning |
US9132135B2 (en) * | 2004-09-24 | 2015-09-15 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
CN101044200A (zh) | 2004-09-24 | 2007-09-26 | 巴尔的摩马里兰大学 | 治疗有机磷中毒的方法 |
WO2008022365A2 (de) * | 2006-08-24 | 2008-02-28 | Sanochemia Ltd. | Mittel zum beeinflussen der wirkungen von organophosphorverbindungen und verwendung von galanthamin, dessen derivaten und analoga zum herstellen solcher mittel |
GB0809905D0 (en) * | 2008-06-02 | 2008-07-09 | Secr Defence | A Transdermal drug delivery device |
RU2612506C2 (ru) | 2011-03-03 | 2017-03-09 | Импел Ньюрофарма Инк. | Устройство для назальной доставки лекарственных средств |
WO2020112766A1 (en) * | 2018-11-26 | 2020-06-04 | Steven Hoffman | Compositions and methods for treating nerve agent exposure |
AU2020276605A1 (en) | 2019-05-14 | 2022-01-20 | Tyme, Inc. | Compositions and methods for treating cancer |
US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
AR207805A1 (es) * | 1975-02-06 | 1976-10-29 | Alza Corp | Substrato apropiado para formar apositos para la dispensacion continua de escopolamina base por via transdermica |
US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
US4278679A (en) * | 1980-05-01 | 1981-07-14 | Chromalloy American Corporation | Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound |
US4952586A (en) * | 1982-08-27 | 1990-08-28 | The Regents Of The University Of California | Edrophonium-atropine composition and therapeutic uses thereof |
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
IL72684A (en) * | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
US5106831A (en) * | 1987-08-13 | 1992-04-21 | State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research | Pharmaceutical composition comprising a spiro oxathiolon/quinuclidine and method of treating senile dementia |
US4981858A (en) * | 1987-08-13 | 1991-01-01 | State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research | Optical isomers |
DE3843239C1 (fi) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
DE3843238C1 (fi) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
EP0523150A4 (en) * | 1990-04-06 | 1993-09-29 | Pharmetrix Corporation | Device and method for enhanced administration of physostigmine |
DE4115558A1 (de) * | 1991-05-13 | 1992-11-19 | Dresden Arzneimittel | Prophylaktisches antidot gegen phosphororganische gifte |
GB9118028D0 (en) * | 1991-08-21 | 1991-10-09 | Secr Defence Brit | Improved transdrmal formulations |
-
1993
- 1993-12-10 DE DE4342174A patent/DE4342174C1/de not_active Ceased
-
1994
- 1994-12-06 HU HU9601569A patent/HUT74432A/hu unknown
- 1994-12-06 CZ CZ19961684A patent/CZ291057B6/cs not_active IP Right Cessation
- 1994-12-06 JP JP51596695A patent/JP3739789B2/ja not_active Expired - Fee Related
- 1994-12-06 NZ NZ277492A patent/NZ277492A/en not_active IP Right Cessation
- 1994-12-06 DE DE59410461T patent/DE59410461D1/de not_active Expired - Lifetime
- 1994-12-06 SK SK739-96A patent/SK284356B6/sk not_active IP Right Cessation
- 1994-12-06 US US08/656,208 patent/US5939095A/en not_active Expired - Lifetime
- 1994-12-06 EP EP95903793A patent/EP0732924B1/de not_active Revoked
- 1994-12-06 AT AT95903793T patent/ATE433339T1/de not_active IP Right Cessation
- 1994-12-06 ES ES95903793T patent/ES2329426T3/es not_active Expired - Lifetime
- 1994-12-06 CA CA002178603A patent/CA2178603C/en not_active Expired - Fee Related
- 1994-12-06 WO PCT/EP1994/004048 patent/WO1995015755A1/de active IP Right Grant
- 1994-12-06 PL PL94314914A patent/PL314914A1/xx unknown
- 1994-12-06 KR KR1019960702988A patent/KR100397361B1/ko not_active IP Right Cessation
- 1994-12-08 MY MYPI94003278A patent/MY111715A/en unknown
- 1994-12-09 ZA ZA949842A patent/ZA949842B/xx unknown
- 1994-12-09 IL IL111942A patent/IL111942A/en not_active IP Right Cessation
-
1996
- 1996-05-27 FI FI962220A patent/FI122131B/fi not_active IP Right Cessation
- 1996-06-07 NO NO962405A patent/NO962405L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH09506360A (ja) | 1997-06-24 |
CZ291057B6 (cs) | 2002-12-11 |
JP3739789B2 (ja) | 2006-01-25 |
EP0732924A1 (de) | 1996-09-25 |
ATE433339T1 (de) | 2009-06-15 |
ZA949842B (en) | 1995-09-01 |
AU1273395A (en) | 1995-06-27 |
HUT74432A (en) | 1996-12-30 |
ES2329426T3 (es) | 2009-11-25 |
HU9601569D0 (en) | 1996-08-28 |
AU703692B2 (en) | 1999-04-01 |
KR960706339A (ko) | 1996-12-09 |
MY111715A (en) | 2000-11-30 |
KR100397361B1 (ko) | 2004-03-24 |
SK284356B6 (sk) | 2005-02-04 |
US5939095A (en) | 1999-08-17 |
SK73996A3 (en) | 1997-01-08 |
CA2178603C (en) | 2005-08-09 |
FI962220A0 (fi) | 1996-05-27 |
CZ168496A3 (en) | 1996-11-13 |
IL111942A0 (en) | 1995-03-15 |
NO962405D0 (no) | 1996-06-07 |
FI122131B (fi) | 2011-09-15 |
CA2178603A1 (en) | 1995-06-15 |
NO962405L (no) | 1996-08-07 |
IL111942A (en) | 1998-02-08 |
NZ277492A (en) | 1998-01-26 |
EP0732924B1 (de) | 2009-06-10 |
DE4342174C1 (de) | 1995-05-11 |
WO1995015755A1 (de) | 1995-06-15 |
DE59410461D1 (de) | 2009-07-23 |
PL314914A1 (en) | 1996-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI962220A0 (fi) | Transdermaalinen terapeuttinen järjestelmä | |
FI954990A0 (fi) | Aktiiviainetta sisältävä transdermaalinen valmiste | |
SE9301171D0 (sv) | Pharmaceutical composition containing lipophilic drugs | |
DE69619052D1 (de) | Feste, wasserfreie, pharmazeutische Zubereitungen für vaginale Verwendung | |
ATE237331T1 (de) | Deuterierte wirkstoffe in transdermaler applikation | |
PT732926E (pt) | Formulacao farmaceutica para a profilaxia ou o pre-tratamento do envenenamento por inibidores de colinesterase organofosforados | |
DE69705110T2 (de) | Topische pharmazeutische zusammensetzungen, welche heparin enthalten | |
ES2176331T3 (es) | Uso de agentes inmunosupresores para el tratamiento de la esquizofrenia. | |
PT695303E (pt) | Sais de piridinio e seu emprego no combate as bacterias helicobacter | |
AR006437A1 (es) | Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene | |
FI884041A (fi) | Desinfiointikoostumus stafylokokkien tappamiseksi | |
BR9714785A (pt) | Composições desinfetantes e processos de desinfecção de superfìcies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 122131 Country of ref document: FI |
|
MM | Patent lapsed |